This is a proposal to continue our studies of the behavioral pharmacology of phencyclidine (PCP) in laboratory animals. PCP abuse remains a serious public health problem requiring a better understanding of its behavioral effects relevant to this abuse. In addition, rapid advances being made in our understanding of the cellular bases for these effects also promise to provide important information about brain-behavior relationships. Previous research has shown that PCP shares many biochemical and behavioral properties with drugs from other chemical classes, including, psychotomimetic opioids such as cyclazocine, (+)-N- allylnormetazocine and dextrorphan. We have also identified others drugs with PCP-like effects such as etoxadrol, dexoxadrol and MK-801. We propose to continue our studies of these PCP- like drugs by studying their discriminative stimulus properties (a model for human subjective effects) in rats and monkeys. An extensive study of structural requirements of opioids for PCP-like effects will facilitate an understanding of receptor-mediation for these effects. We also propose to compare the effects of PCP and these PCP-like drugs in other behavioral procedures to determine the extent of the overlap in their effects and to address the question whether the PCP receptor may be involved in these effects and whether specificity of action can be obtained. Procedures to be used include i.v. drug self-administration, an animal model of anxiolytic effects, interactions with CNS- depressant drugs and cross dependence studies. We will follow up our findings of dependence upon PCP with additional studies to determine the role of dependence in PCP self-administration. Finally, a major new direction for the project is to investigate the role of excitatory amino acid neurotransmission in the behavioral actions of PCP by evaluating the hypothesis that PCP has opposing actions to N-methyl-d-aspartate. These studies may lead to the identification of therapeutic uses of PCP-like drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA001442-16
Application #
3206907
Study Section
Special Emphasis Panel (SRCD (02))
Project Start
1976-04-01
Project End
1993-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
16
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Burgdorf, Jeffrey; Zhang, Xiao-lei; Nicholson, Katherine L et al. (2013) GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 38:729-42
Morgan, Richard W; Nicholson, Katherine L (2011) Characterization of the antinociceptive effects of the individual isomers of methadone after acute and chronic administrations. Behav Pharmacol 22:548-57
Bhat, Shrihari J S; Blank, Melissa D; Balster, Robert L et al. (2010) Areca nut dependence among chewers in a South Indian community who do not also use tobacco. Addiction 105:1303-10
Lynch, Wendy J; Nicholson, Katherine L; Dance, Mario E et al. (2010) Animal models of substance abuse and addiction: implications for science, animal welfare, and society. Comp Med 60:177-88
Nicholson, Katherine L; Balster, Robert L (2009) The discriminative stimulus effects of N-methyl-D-aspartate glycine-site ligands in NMDA antagonist-trained rats. Psychopharmacology (Berl) 203:441-51
Johanson, Chris-Ellyn; Balster, Robert L; Henningfield, Jack E et al. (2009) Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report. Drug Alcohol Depend 105 Suppl 1:S65-71
Nicholson, Katherine L; Balster, Robert L; Golembiowska, Krystyna et al. (2009) Preclinical evaluation of the abuse potential of the analgesic bicifadine. J Pharmacol Exp Ther 330:236-48
Acosta, Michelle C; Eissenberg, Thomas; Nichter, Mimi et al. (2008) Characterizing early cigarette use episodes in novice smokers. Addict Behav 33:106-21
Nicholson, Katherine L; Mansbach, Robert S; Menniti, Frank S et al. (2007) The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101 606 in rats and rhesus monkeys. Behav Pharmacol 18:731-43
Dravid, Shashank M; Erreger, Kevin; Yuan, Hongjie et al. (2007) Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block. J Physiol 581:107-28

Showing the most recent 10 out of 63 publications